Treatment of bipolar depression

New England Journal of Medicine

Volumn 356, Issue 17, 2007, Pages 1771-1773

  Belmaker, R H ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LAMOTRIGINE; MOOD STABILIZER;

BIPOLAR DISORDER; CELL HETEROGENEITY; CLINICAL FEATURE; DEPRESSION; DISEASE CLASSIFICATION; DRUG EFFICACY; EDITORIAL; ELECTROSTIMULATION; FAMILY ATTITUDE; HUMAN; MANIA; MONOTHERAPY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 34247539027     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe078042     Document Type: Editorial

References (14)

1. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000;157:124-6.
2. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537-47.
3. Moller HJ, Grunze H, Broich K. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci 2006;256:1-16.
4. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006;163:232-9.
5. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:1711-22.
6. Osher Y, Yaroslavsky Y, el-Rom R, Belmaker RH. Predominant polarity of bipolar patients in Israel. World J Biol Psychiatry 2000;1:187-9.
7. Shapiro DR, Quitkin FM, Fleiss JL. Response to maintenance therapy in bipolar illness: effect of index episode. Arch Gen Psychiatry 1989;46:401-5.
8. Angst J. Clinical typology of bipolar illness. In: Belmaker RH, van Praag HM, eds. Mania: an evolving concept. Jamaica, NY: SP Medical & Scientific Books, 1980:61-76.
9. Klein DF, Gittleman R, Quitkin FM, Rifkin A. Diagnosis and drug treatment of psychiatric disorders: adults and children. 2nd ed. Baltimore: Williams & Wilkins, 1980.
10. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400. [Erratum, Arch Gen Psychiatry 2004;61:680.]
11. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88.
12. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-14.
13. Grunhaus L, Schreiber S, Dolberg OT, Hirshman S, Dannon PN. Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord 2002;4:Suppl 1:91-3.
14. Levine J, Applebaum J, Belmaker RH. Novel treatments of bipolar depression. In: El-Mallakh RS, Ghaemi SN, eds. Bipolar depression: a comprehensive guide. Washington, DC: American Psychiatric Publishing, 2006:191-214.